Filing metadata

Accession number
0000950170-23-049003
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 20, 2023
Reporting period
Sep 19, 2023
Description
Insider transaction

Explore SEC Filings Hub